Autres langues DarioHealth Corp.

Actions

DRIO

US23725P2092

Temps Différé Nasdaq Autres places de cotation 20:27:30 09/05/2024			Varia. 5j.	Varia. 1 janv.
1,658 ^USD	+3,01 %		+9,11 %	-3,58 %

25/04	DarioHealth Corp. publie une nouvelle étude évaluée par des pairs qui renforce les preuves que la gestion des conditions cardiométaboliques au sein d'une plateforme intégrée améliore les résultats cliniques.	CI
18/04	DarioHealth Corp. signe avec deux employeurs pour la suite cardiométabolique avec solution Glp-1 intégrée	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

DarioHealth to Report First Quarter 2024 Results on Wednesday, May 15th	07/05
Dario Publishes New Peer-Reviewed Study that Deepens the Body of Evidence that Managing Cardiometabolic Conditions in One Integrated Platform Improves Clinical Outcomes	25/04
DarioHealth Corp. Publishes New Peer-Reviewed Study That Deepens the Body of Evidence That Managing Cardiometabolic Conditions in One Integrated Platform Improves Clinical Outcomes	25/04
Dario Signs Two Employers for Cardiometabolic Suite with Integrated GLP-1 Solution	18/04
DarioHealth Corp. Signs Two Employers for Cardiometabolic Suite with Integrated Glp-1 Solution	18/04
Dario Publishes Two New Peer-Reviewed Studies Demonstrating Impact of Digital Behavioral Health	10/04
DarioHealth Corp. Publishes Two New Peer-Reviewed Studies Demonstrating Impact of Digital Behavioral Health	10/04
TWO NATIONAL EMPLOYERS SELECT DARIO S INTEGRATED CHRONIC CONDITION SOLUTION TO IMPROVE EMPLOYEE HEALTH	03/04
Two National Employers Select Dario's Integrated Chronic Condition Solution to Improve Employee Health	02/04
Two National Employers Select DarioHealth Corp.'S Integrated Chronic Condition Solution to Improve Employee Health	02/04
DarioHealth : Q4 and full year 2023 earnings call transcript	01/04
DarioHealth Reports Fourth Quarter and Full-Year 2023 Financial and Operating Results	28/03
DarioHealth Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	28/03
North American Morning Briefing : Stocks Set for -2-	28/03
DARIOHEALTH TO REPORT FOURTH QUARTER 2023 RESULTS ON THURSDAY, MARCH 28TH	21/03
North American Morning Briefing : Investors -2-	21/03
New Research from Dario Demonstrates Ability to Deliver Improved Health Outcomes with Integrated Solution for Members Managing Weight and Blood Glucose with or without GLP-1 Medications	12/03
DarioHealth Corp. Announces Two New Clinical Studies Presented at the 17th International Conference on Advanced Technologies and Treatments for Diabetes 2024	12/03
DARIOHEALTH TO PARTICIPATE IN THE COWEN 43RD ANNUAL HEALTHCARE CONFERENCE	28/02
DarioHealth Corp. Appoints Tomer Ben-Kiki as Chief Operating Officer	21/02

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues DarioHealth Corp.

Actions

DRIO

US23725P2092

Autres langues

Filtres